Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry
Dual antiplatelet therapy: how, how long, and in which patients?
Ticagrelor With or Without Aspirin After Complex PCI
Clopidogrel Pharmacogenetics: State-of-the-Art Review and the TAILOR-PCI Study
Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial
Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial
Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI)
Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.